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RNA-Seq promises to be used in clinical settings as a gene-expression profiling tool; however, questions about its variability 
and biases remain and need to be addressed. Thus, RNA controls with known concentrations and sequence identities originally 
developed by the External RNA Control Consortium (ERCC) for microarray and qPCR platforms have recently been proposed 
for RNA-Seq platforms, but only with a limited number of samples. In this study, we report our analysis of RNA-Seq data 
from 92 ERCC controls spiked in a diverse collection of 447 RNA samples from eight ongoing studies involving five species 
(human, rat, mouse, chicken, and Schistosoma japonicum) and two mRNA enrichment protocols, i.e., poly(A) and RiboZero. 
The entire collection of datasets consisted of 15650143175 short sequence reads, 131603796 (i.e., 0.84%) of which were 
mapped to the 92 ERCC references. The overall ERCC mapping ratio of 0.84% is close to the expected value of 1.0% when 
assuming a 2.0% mRNA fraction in total RNA, but showed a difference of 2.8-fold across studies and 4.3-fold among samples 
from the same study with one tissue type. This level of fluctuation may prevent the ERCC controls from being used for 
cross-sample normalization in RNA-Seq. Furthermore, we observed striking biases of quantification between poly(A) and Ri-
boZero which are transcript-specific. For example, ERCC-00116 showed a 7.3-fold under-enrichment in poly(A) compared to 
RiboZero. Extra care is needed in integrative analysis of multiple datasets and technical artifacts of protocol differences should 
not be taken as true biological findings. 
RNA-Seq, External RNA Control Consortium (ERCC), MAQC/SEQC, mRNA enrichment protocol, quality control, 
reproducibility, quantification bias, poly(A) versus RiboZero 
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RNA-Seq provides a new way at the genome-wide scale to 
measure gene expression profiles, distinguish isoforms, 
identify new transcripts, and make many other biomedical 
applications possible [1–3]. RNA-Seq has shown its accu-
racy for the quantification of gene expression levels, as de-
termined by quantitative PCR. Its high level of technical 
reproducibility has also been demonstrated [4–6]. Despite 
these advantages, recent analyses have revealed larger tech-
nical variability for the quantification of genes expressed at 
lower levels [7] and biases introduced by RNA-Seq tech-
nologies and the normalization methods [8–10]. However, 
most of these studies lack the absolute “truth” to objectively 
assess the performance and biases of RNA-Seq technology 
and the impact of data analysis approaches.  
The External RNA Control Consortium (ERCC), a group 
of about 70 scientists from private, public and academic 
organizations led by the National Institute of Standards 
(NIST), developed a series of spike-in RNA transcripts with 
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known concentrations and sequence identities and originally 
proposed for their use in quality assessment/control of gene 
expression platforms such as microarrays and qPCR 
[1113]. Specifically, these external RNA standard controls 
can provide a powerful tool for comparing relationship be-
tween the measured signal response and the known input 
concentration of the controls. A good linear relationship 
would be an indication of reliable estimation of the expres-
sion measurements for endogenous RNA transcripts [11,12, 
14].  
Recently, the ERCC spike-in controls of known concen-
trations and sequences have been proposed for assessing the 
performance of RNA-Seq technology and data analysis ap-
proaches [15–17]. However, the type and the number of 
RNA samples spiked with ERCC controls are limited. Be-
fore the ERCC controls can be routinely and reliably used in 
RNA-Seq studies for quality monitoring, their behavior in 
more diverse and biologically relevant RNA matrices needs 
to be investigated. 
In this study, we analyzed a collection of eight RNA-Seq 
datasets consisting of 447 unique total RNA samples iso-
lated from five species (Homo sapiens, Rattus norvegicus, 
Mus musculus, Gallus gallus, and Schistosoma japonicum). 
Each of these 447 RNA samples was spiked with one of the 
two ERCC control mixes according to the manufacturer’s 
guidelines (Life Technologies, see Materials and methods 
for more details). For most samples, one of the two mRNA 
enrichment protocols, poly(A) selection and RiboZero, was 
used before Illumina sequencing. For some RNA samples, 
the two mRNA enrichment protocols were applied and rep-
licate libraries were made under each protocol. In addition, 
each library was sequenced on multiple lanes of a flow cell. 
The datasets allowed us to examine the behavior of the 
ERCC controls under diverse environments and should pro-
vide helpful information for the practical applicability of 
ERCC controls in RNA-Seq studies. On the other hand, the 
datasets also provided an opportunity for us to objectively 
assess the performance of the Illumina platform.  
1  Materials and methods 
1.1  ERCC Mix1 and Mix2 
The two ERCC control mixtures (Mix1 and Mix2) were 
purchased from Life Technologies Corp. (Carlsbad, Cali-
fornia, USA; http://www.invitrogen.com/). They are pre- 
formulated pools of 92 polyadenylated transcripts with 
length of 2502000 nt and a span of approximately 106-fold 
difference in concentration. Each of the two mixtures con-
tains the same set of 92 ERCC transcripts which are sepa-
rated into four sub-pools (A, B, C, and D) each with 23 
transcripts. The difference between Mix1 and Mix2 is the 
relative amounts of the four sub-pools, resulting in 
pre-defined Mix1:Mix2 concentration ratios of 4.0, 1.0, 0.67, 
and 0.50 for sub-pools A, B, C and D, respectively. Each 
RNA sample was spiked in with an appropriate amount of 
either Mix1 or Mix2 according to Life Technologies’ guide-
lines which would lead to about 1% of the total number of 
RNA-Seq reads mapping to the 92 ERCC control sequences, 
assuming the mRNA fraction in the total RNA is 2%. Over-
all, about half of the 447 RNA samples were spiked with 
Mix1 and the other half with Mix2. The use of Mix1 and 
Mix2 in the same study also allows one to assess the accu-
racy of fold changes estimated by RNA-Seq.  
1.2  Eight datasets with two mRNA enrichment proto-
cols and five species  
The eight RNA-Seq datasets with ERCC spike-ins are 
summarized in Table 1. They came from our ongoing 
RNA-Seq studies involving five species (Homo sapiens, 
Rattus norvegicus, Mus musculus, Gallus gallus, and Schis-
tosoma japonicum) with 447 unique total RNA samples, 
each of which was pre-spiked with ERCC Mix1 or Mix2 
before library preparation and sequencing in such a way so 
that about 1% of the sequenced reads is expected to map to 
the sequences of the 92 ERCC transcripts (assuming a 2% 
mRNA content in the total RNA [18]). Both poly(A) selec-
tion and RiboZero protocols were used for mRNA enrich-
ment. Standard Illumina library preparation and sequencing 
protocols were used throughout these studies. Briefly, 
cDNA libraries were prepared for each sample and se-
quenced using Illumina’s TruSeq Cluster v3 and TruSeq 
SBS kit v3. Usually, multiple indexed libraries from the 
same study were pooled together and loaded for sequencing 
on multiple lanes of an Illumina flow cell using either an 
Illumina HiScan or HiSeq 2000 sequencer. Library prepara-
tion and sequencing were conducted at the City of Hope 
Functional Genomics Core (Duarte, California, USA), the 
University of Texas Southwestern Medical Center’s Micro-
array Core (Dallas, Texas, USA), or Expression Analysis 
Inc. (Durham, North Carolina, USA). 
For most samples, only one library was built; however, 
for the purpose of estimating library reproducibility, two 
replicate libraries were constructed per sample for study 
Rn_RZ_2 and study Rn_PA. This allowed us to compare 
the repeatability and reproducibility between different stud-
ies and at different replication levels. The statistics of reads 
mapping to ERCC reference sequences in each study are 
listed in Table 1. To the best of our knowledge, this repre-
sents the largest and most diverse collection of RNA-Seq 
datasets with ERCC spike-in mixes so far.  
1.3  Reads mapping and normalization 
RNA-Seq reads were aligned to the ERCC reference se-
quences by using Bowtie2 [19], with a maximum of 2 mis-
matches allowed. The other default parameter settings were 
used. The alignment results were then processed using 
SAMtools [20] to filter the mapped reads, followed by 
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Hm_PA Hs Poly(A) 20 50 SE 21782082 435641643 196156 3923113 0.61% 1.52% 2.51 0.90% 0.25% 
Rn_RZ_1 Rn RiboZero 320 50 SE 41333962 13226867952 363409 116290946 0.35%**** 3.46% 9.88 0.92% 0.35% 
Rn_RZ_2 Rn RiboZero 2** 100 PE 94308066 188616132 660639 1321278 0.69% 0.71% 1.03 0.70% 0.01% 
Rn_PA Rn Poly(A) 2** 100 PE 113520882 227041764 540195 1080389 0.42% 0.55% 1.32 0.48% 0.09% 
Ms_PA_1 Mm Poly(A) 16 50 PE 20353995 325663925 79468 1271490 0.20% 0.79% 3.84 0.40% 0.16% 
Ms_PA_2 Mm Poly(A) 27 50 PE 12480732 336979765 137508 3712728 0.64% 2.73% 4.30 1.14% 0.47% 
Gg_PA Gg Poly(A) 36 101 SE 17775776 639927940 70299 2530776 0.19% 0.80% 4.27 0.40% 0.18% 






     
a) *, Hs: Homo sapiens; Rn: Rattus norvegicus; Mm: Mus musculus; Gg: Gallus gallus; Sj: Schistosoma japonicum; **, these RNA samples were ob-
tained from the same biological tissues; therefore, they are aliquots of the same RNA isolation; ***, SE: single-end; PE: paired-end; ****, two samples 
showed ERCC mapping ratios of <0.001%; it was suspected that no ERCC mix was spiked in due to experimental errors.  
 
BEDTools [21]  for counting reads mapped to each ERCC 
transcript. For RNA samples with multiple replicating li-
braries and/or sequencing replicates (i.e., loaded on multiple 
lanes), the total number of reads for each ERCC transcript 
was calculated and normalized using the following formula: 
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where i represents the ith ERCC transcript (from 1 to 92); j 
is the jth RNA sample in a study (from 1 to 447); m is the 
number of sequencing replicates per RNA sample; n is the 
number of total RNA samples, and Ri,j is the total number of 
reads mapped to ERCC transcript i in RNA sample j. Xi,j is 
the normalized expression value for ERCC transcript i in 
sample j. 
1.4  Data analysis methods 
The ERCC mapping ratio for a given RNA sample was cal-
culated as the number of reads mapped to the 92 ERCC 
transcripts divided by the total number of reads sequenced 
for that RNA sample. Principal component analysis (PCA), 
principal variance component analysis (PVCA), ERCC 
concentration versus RNA-Seq quantification curves, and 
Pearson correlation coefficient were performed in the R 
(www.r-project.org/) environment with its “base” functions 
and “stat” packages. The normalized reads counts in log2 
scale defined above in Section 1.3 were used for PCA, 
PVCA and Pearson correlation by “prcomp” and “cor” 
function in the “stat” and “lme4” packages. The linear mod-
el fitting plots were generated with the “ggplots2” packages 
(http://had.co.nz/ggplot2/ book).  
2  Results  
2.1  The percentage of reads mapped to ERCC spike-in 
controls varies among studies and samples 
We first examined the percentage of RNA-Seq reads from 
an RNA sample mapped to the 92 ERCC control sequences. 
Figure 1A shows the individual percentages for the 447 
samples and Table 1 lists the summary information of the 
mapping ratio by study. As expected, for most samples the 
ERCC reads accounted for around 1% of the total se-
quenced reads. However, the mean mapping ratio did show 
appreciable differences among various studies, ranging 
from 0.40% for study Gg_PA with Gallus gallus to 1.14% 
for study Ms_PA_2 with Mus musculus, representing a 
2.8-fold difference across studies. We also observed large 
variations in ERCC mapping ratio for some samples in the 
same study. For example, in the Ms_PA_2 study, the highest 
mapping ratio is 2.73%, whereas the lowest mapping ratio is 
only 0.64%, representing a 4.3-fold difference among sam-
ples. In addition, in the Rn_RZ_1 study one sample showed a 
very high mapping ratio of 3.46%, whereas the lowest map-
ping ratio in the same study is only 0.35% (excluding the two 
samples for which ERCC mixtures apparently were not 
spiked in), representing a 9.9-fold difference. 
We further summarized the Rn_RZ_1 study data by sep-
arating the RNA samples according to tissue type (Table 2). 
The mean ERCC mapping ratio per tissue type varied from 
0.67% for adrenal gland to 1.49% for liver, or a 2.2-fold dif-
ference across tissue types. Furthermore, the ERCC mapping 
ratio varied up to 5.0-fold across the 32 liver samples. 
2.2   Principal component analysis shows clear group-
ing of samples by the type of spike-in mixtures and by 
mRNA enrichment protocols 
PCA was performed on the 92 by 447 matrix of ERCC 
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32 43786644 1401172623 288987 9247569 0.35% 0.92% 2.61 0.67% 0.11% 
Testes 16 45205366 723285852 308164 4930625 0.41% 1.24% 2.99 0.69% 0.22% 
Kidney 32 47282344 1513035020 352091 11266904 0.55% 1.20% 2.18 0.76% 0.20% 
Lung 32 43764138 1400452416 334477 10703250 0.53% 1.08% 2.03 0.77% 0.13% 
Brain 32 44040794 1409305414 337998 10815923 0.50% 1.17% 2.34 0.79% 0.17% 
Heart 32 48174059 1541569887 409255 13096164 0.55% 1.70% 3.11 0.85% 0.24% 
Thymus 32 38897728 1244727299 354675 11349614 0.50% 2.31% 4.66 0.91% 0.34% 
Uterus 16 43672502 698760031 404171 6466729 0.58% 2.35% 4.09 0.96% 0.46% 
Muscle 32 34291628 1097332090 358838 11482824 0.75% 1.58% 2.11 1.05% 0.20% 
Spleen 32 37445301 1198249628 392967 12574932 0.61% 1.40% 2.30 1.06% 0.28% 
Liver 32 31218053 998977692 448638 14356412 0.69% 3.46% 5.02 1.49% 0.47% 





     
 
 
Figure 1  Percentage of RNA-Seq reads mapped to the 92 ERCC controls. It was calculated by dividing the number of reads mapped to the 92 ERCC ref-
erence sequences by the total number of sequence reads collected for an RNA sample. The 447 RNA samples were ordered first by study, then by tissue type 
(for study Rn_RZ_1 only), and lastly by the mapping ratio (percentage). Samples in study Rn_RZ_1 (colored in blue) were separated into 11 tissue types that 
were sorted by the mean mapping ratio per tissue type. 
quantification data; the proportion of the total variance ex-
plained by the first and second principal components (PC1 
and PC2) is 31.8% and 19.6%, respectively (Figure 2A). 
Samples were firstly grouped according to the type of 
ERCC mixtures (PC1), as expected due to the different 
compositions of the Mix1 and Mix2 mixtures, then by dif-
ferent RNA enrichment protocols (PC2). For the Rn_PA 
and Rn_RZ_2 studies, the same RNA samples were en-
riched for mRNA by the poly(A) selection and RiboZero 
protocols, and the resulting ERCC expression profiles 
(samples from Rn_RZ_2 were colored in black and green 
for Rn_PA) clustered together with samples enriched using  
the same mRNA enrichment protocol. This shows that the 
choice of mRNA enrichment protocols plays an important 
role on the quantification characteristics of the ERCC con-
trols as determined by RNA-Seq.  
2.3   Principal variance component analysis 
To further quantitatively understand the factors that con-
tribute to the variation in ERCC quantification profiles, we 
performed PVCA based on all 447 samples. The results 
were shown in Figure 2B. The ERCC “Mixture Type” ex-
plained 49.2% of the total variance, followed by mRNA 
enrichment protocols that accounted for 19.5% of the total 
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Figure 2  Factors impacting the variation in the quantification of ERCC spike-in controls. A, Principal component analysis shows that the 447 samples 
were firstly clustered by mixture type (Mix1 or Mix2), then by mRNA enrichment protocol (RiboZero or poly(A)). Studies Rn_PA and Rn_RZ_2 (colored in 
green and black, respectively) represents data from applying the two mRNA enrichment protocols to the same RNA. B, Principal variance component analy-
sis quantifies the proportion of variance explained by each experimental factor. 
variance. Intriguingly, the variance explained by study or 
species alone is quite low and accounted for only 0.52% and 
0.34%, respectively, much smaller than the residuals 
(8.97%). We also observed that the interactions of mixture 
type with mRNA selection protocol and study accounted for 
12.2% and 4.91% of the total variance, respectively. These 
results further demonstrated that the choice of mRNA en-
richment protocols dramatically impact the behavior (quan-
tification) of ERCC control transcripts by RNA-Seq. 
2.4   Repeatability and reproducibility of ERCC spike- 
in abundance estimated by RNA-Seq 
To further understand the degree of variation resulting from 
different experimental factors, we assessed the consistency 
of expression values of the 92 ERCC controls under differ-
ent experimental scenarios. The scatterplots in Figure 3 
show the repeatability of sequencing data collected from the 
same library but on two different lanes of the same flow cell 
(A, sequencing replicates), the repeatability of two libraries 
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Figure 3  Consistency of RNA-Seq data at different replication levels including sequencing, library, study, and mRNA enrichment protocol. A, Two dif-
ferent sequencing replicates (two lanes on the same flow cell) of the same library. B, Two libraries constructed from the same RNA sample. C, Two different 
studies using the same poly(A) protocol. D, Two different mRNA enrichment protocols. Several ERCC-transcripts (e.g., ERCC-00116) show significantly 
different RNA-Seq signals between the two protocols. Each dot represents one of the 92 ERCC spike-in controls. Mix2 data were plotted. 
constructed from the same RNA sample (B, library repli-
cates), the reproducibility of quantification of ERCC con-
trols measured in two unrelated studies using the same 
poly(A) selection protocol (C, different studies), and the 
consistency between poly(A) and RiboZero based libraries 
from the same RNA sample (D, different mRNA enrich-
ment protocols). A high correlation coefficient was obtained 
between sequencing technical replicates (Pearson’s correla-
tion coefficient r=0.9914). The correlation between two 
different libraries from same sample is slight lower than that 
between sequencing technical replicates (r=0.9912). This 
indicates a good repeatability of sequencing technology and 
library preparation. In addition, a reasonably good correla-
tion (r=0.9861) between two different studies suggests that 
the quantification of ERCC controls used in different stud-
ies are comparable.  
2.5   Poly(A) versus RiboZero enrichment protocols 
We also compared the replicate samples with different 
mRNA selection protocols (Figure 3D). Although there is a 
good overall correlation (r=0.9748), several ERCC controls 
such as ERCC-00116 behaved dramatically different be-
tween the two mRNA enrichment protocols. For example, 
the RNA-Seq estimated abundance for ERCC-00116 in the 
poly(A) protocol was 7.3-fold (p=1.4×1018) lower com-
pared to that in the RiboZero protocol. An important differ-
ence between Figure 3D and the other three panels in Figure 
3 is that the inconsistency between the two mRNA enrich-
ment protocols occurs not only for ERCC controls at low 
concentrations due to low abundance (lower-left) but also 
for controls with high concentrations (upper-right). This 
indicates that the deviation between the two protocols is not 
simply because of the sequencing depth but something in-
herently different between the two protocols.  
2.6   Relationship between RNA-Seq counts and ERCC 
concentrations 
In Figure 4, we plotted the normalized RNA-Seq counts 
versus the concentrations for the 92 ERCC spike-in controls 
for RiboZero (Figure 4A) and poly(A) (Figure 4B) data. 
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Figure 4  Relationship between ERCC control concentration and RNA-Seq measured signal in log2 scale. A, RiboZero protocol; the gray area represents 
the range of standard error and black line is the liner model curve. B, poly(A) protocol. Each dot represents one of the 92 ERCC spike-in controls. Mix1 data 
were plotted. 
There is an overall linear relationship between RNA-Seq 
detected signal and the true concentration of the ERCC con-
trols, especially for controls with higher concentrations. At 
the lower concentration end (lower-left), RNA-Seq was 
unable to detect concentration gradient. Interestingly, for 
ERCC-00116 the RNA-Seq detected signal with poly(A) 
protocol was almost 4-fold lower than expected, whereas 
the RNA-Seq signal with RiboZero was almost 2-fold high-
er than expected. These two opposite biases led to a 7.3-fold 
difference between the two mRNA enrichment protocols for 
ERCC-00116 shown in Figure 3D. 
3  Discussion 
The external RNA controls originally developed for moni-
toring the performance of microarray and qPCR platforms 
of gene expression have recently been proposed for the 
same purpose for RNA-Seq, a rapidly-evolving technology 
with the potential for more accurate and reliable gene ex-
pression measurement. Our study included a collection of 
eight datasets consisting of 447 unique RNA samples from 
five species pre-spiked with ERCC control mixes. To the 
best of our knowledge, this collection of datasets represents 
the largest and most diverse RNA-Seq analysis to date with 
external RNA standards and the observations from these 
datasets on the quantification characteristics of the ERCC 
controls should become useful for future applications and 
interpretation of RNA-Seq data.  
We observed dramatic impact of mRNA enrichment 
methods on the behavior of ERCC controls in the RNA-Seq 
experiments. Specifically, the poly(A) enrichment protocol 
resulted in under selection of certain ERCC controls, most 
notably for ERCC-00116 that showed a 7.3-fold of under 
enrichment in the poly(A) protocol compared to the Ribo-
Zero protocol. It should be pointed out that the poly(A) se-
lection biases observed in this study is not unique to 
RNA-Seq, because the poly(A) selection procedure is also 
widely used in microarray-based gene expression studies. 
Our observation on poly(A) selection biases has several 
implications in the applications of gene expression data in 
biomedical research. First, extra care must be exercised in 
the integrative analysis and interpretation of multiple 
gene-expression datasets resulting from different mRNA 
enrichment protocols. Otherwise, research findings may be 
merely artifacts of protocol differences rather than true bio-
logical signal that we set to discover. Secondly, although 
there is in general a good agreement between the concentra-
tion of spike-in controls and the RNA-Seq reads count, it is 
difficult to accurately estimate the absolute expression level 
of RNA transcripts, because the level of RNA-Seq meas-
urement biases is clearly protocol dependent and transcript 
specific. Future attempts for correcting protocol dependent 
and transcript-specific biases are welcome but will be chal-
lenging. Thirdly, a decision to switch the mRNA enrich-
ment protocol in the middle of a large study should not be 
made lightly and its implications should be adequately as-
sessed. 
The entire collection of datasets used in this analysis 
consists of 15650143175 RNA-Seq reads, 131603796 (i.e., 
0.84%) of which were successfully mapped to the 92 ERCC 
reference sequences. This ERCC mapping ratio (0.84%) is 
close to what is expected from the manufacturer’s guide-
lines on the use of the ERCC controls. However, the actual 
ERCC mapping ratio showed significant level of variation 
among studies, ranging from 0.40% to 1.14%, or a 2.8-fold 
difference across studies. In addition, the ERCC mapping 
ratio among samples from the same study involving only  
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one tissue type showed up to a 4.3-fold difference between 
the maximum and minimum ratios (Table 1, excluding 
study Rn_RZ_1). The difference in ERCC mapping ratio 
among various studies may reflect the inherent difference in 
mRNA fraction in the type of RNA samples profiled. In-
deed, in the Rn_RZ_1 study where 11 different rat tissue 
types were separately analyzed (Table 2), we observed a 
clear tissue-dependence of ERCC mapping ratio: the ratio is 
the highest for liver (1.49%) and the lowest for adrenal 
gland (0.67%). On the other hand, the fluctuation of ERCC 
mapping ratio among samples in the same study involving 
only one tissue type may reflect the true accumulated tech-
nical variability in measuring RNA concentrations, pipet-
ting RNA samples and ERCC controls, the completeness of 
mRNA enrichment, and preparing and sequencing the li-
braries. It seems to us that an up to 4.3-fold difference in 
ERCC mapping ratio may prevent the effective use of 
ERCC reads count as a basis for cross-sample normalization 
in RNA-Seq. 
Another interesting observation in our study is that two 
RNA samples in the Rn_RZ_1 study were clearly not 
spiked with any ERCC mixes (Table 1), because their map-
ping ratio was <0.001%, which is at the level of mapping 
background (data not shown). Mislabeling of sample iden-
tity, which may be resulting from mis-pipetting, presents a 
common problem in the four large RNA-Seq studies in the 
US Food and Drug Administration (FDA) initiated SE-
quencing Quality Control (SEQC) project (http://www. 
fda.gov/MicroArrayQC/), which is the third phase of the 
FDA initiated, community-wide MicroArray Quality Con-
trol (MAQC) project [22,23]. In the SEQC project, it was 
estimated that 2%3% of the ~2000 samples were 
mis-labeled or mis-pipetted (Shi L, personal communica-
tions) based on the availability of technical and biological 
replicates and cross-check of the sample annotation infor-
mation. This raises serious concerns on the need of mini-
mizing and preventing the occurrence of sample mis-   
labeling in clinical settings where RNA-Seq and other di-
agnostics platforms are expected to be used as routine 
equipment and no technical replicates are usually available 
for assisting the identification of mislabeling.  
It should be pointed out that relative, not absolute 
gene-expression analysis is the main use of microarray and 
RNA-Seq gene profiling. In this study we did not examine 
the behavior of ERCC controls in terms of differential ex-
pression. In addition, we did not investigate the molecular 
reasons leading to the transcript-specific biases under dif-
ferent mRNA enrichment protocols. Furthermore, another 
potentially useful utility of the ERCC controls is to help 
identify outlier samples in an RNA-Seq study, but we failed 
to identify any obvious outlying samples in our studies. 
Therefore, our current study cannot conclude on the effec-
tiveness of ERCC controls for outlier identification purpos-
es. Nevertheless, the amount of new information that can be 
gained from the ERCC spike-in controls justifies their con-
tinued uses in future RNA-Seq studies so that the behavior 
of the spike-in controls themselves and the endogenous 
RNA transcripts under more diverse experimental condi-
tions can be better evaluated. The ERCC spike-in data pre-
sented in this study should also prove useful for evaluating 
the performance of different sequencing platforms and var-
ious data analysis approaches. 
The ERCC spike-in data reported in this study were extracted from ongo-
ing RNA-Seq projects in collaboration with our collaborators. We are 
grateful to them for allowing us to use the ERCC data in this study.  
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